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background:  Cocaine use is a well-recognized risk factor for coronary heart disease (CHD). Systematic information is lacking, however, regarding 
the clinical features and outcomes related to cocaine-associated ST-elevation myocardial infarction (STEMI), particularly in low-income urban 
communities.
methods: We characterized patients with acute STEMI evaluated for primary revascularization at Montefiore Medical Center (MMC) according to 
cocaine-use status. Between 2008 and 2012, clinical information on all such patients was collected in a prospective registry. This was supplemented 
and linked to outcomes using an electronic search engine for clinical and administrative data across MMC, the principal provider for the 1.4 million 
residents of the Bronx, NY. Active cocaine use was documented by medical interview. Deaths were obtained from MMC records and the National 
Death Index. Recurrent cardiovascular disease (CVD) hospitalization included CHD, heart failure, and stroke by ICD-9 codes.
results: There were 785 patients (age 59; 31% women; 18% white, 18% black, 42% Hispanic; socioeconomic score -2.4), of whom 48 (6%) had 
documented cocaine use. Cocaine-related STEMI was associated with younger age (52 vs. 60), more smoking (77% vs. 36%), and HIV+ status (8% 
vs. 2%), but less hypertension (47% vs. 67%), diabetes (18% vs. 37 %), and three-vessel disease (13% vs. 26%), than cocaine-unrelated STEMI 
(all p≤0.05). There were no differences in culprit lesion or referral for bypass surgery. Patients with documented cocaine less frequently received 
drug-eluting stents (18% vs. 46%, p<0.001) or beta-blockers (70% vs. 81%, p=0.07). During a 2.1-year median follow-up, 307 patients died or had 
recurrent hospitalization for CVD. Incidence rates were high in both groups, and did not differ significantly between cocaine-users and non-users (16 
vs. 18 per 100 patient-years, p=0.62).
Conclusions: In this low-income community, cocaine-use occurred in a substantial fraction of cases, and was associated with a high rate of 
adverse outcomes. These data suggest that programs targeting cocaine abuse and smoking could contribute importantly to CHD prevention in 
disadvantaged communities.
